Lentigen

Gaithersburg, United States Founded: 2004 • Age: 22 yrs Acquired By Miltenyi Biotec
Lentiviral vectors are developed for pre-clinical and clinical applications.
Request Access

About Lentigen

Lentigen is a company based in Gaithersburg (United States) founded in 2004 was acquired by Miltenyi Biotec in August 2014.. Lentigen has completed 1 acquisition, including Living Pharma. Lentigen operates in a competitive market with competitors including StrideBio, LogicBio, Phase Genomics, Candel Therapeutics and Sixfold Bioscience, among others.

  • Headquarter Gaithersburg, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.2 M (USD), Grant

    Nov 04, 2010

  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Miltenyi Biotec

    (Aug 14, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Lentigen

  • Total Funding
  • Total Rounds 12
  • Last Round Grant — $1.2M
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2010 Amount Grant - Lentigen Valuation

investors

Sep, 2010 Amount Grant - Lentigen Valuation

investors

HHS
Jun, 2010 Amount Grant - Lentigen Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lentigen

Lentigen has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Miltenyi Biotec and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Develops tools and products for research and clinical application
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lentigen

Lentigen has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Living Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Personalized anti-tag CAR T cell therapies for cancer are developed.
2015
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Lentigen

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lentigen Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lentigen

Lentigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as StrideBio, LogicBio, Phase Genomics, Candel Therapeutics and Sixfold Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AAV-based gene therapies for rare diseases are developed.
domain founded_year HQ Location
Viral vectors are developed for genetic and infectious disease treatments.
domain founded_year HQ Location
Laboratory and computational services for DNA proximity analysis are provided.
domain founded_year HQ Location
Viral immunotherapies are developed for cancer treatment.
domain founded_year HQ Location
Oligonucleotide delivery systems are developed for targeted gene therapy.
domain founded_year HQ Location
Genetic medicines are delivered using polymer nanoparticle platforms.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Lentigen

Frequently Asked Questions about Lentigen

When was Lentigen founded?

Lentigen was founded in 2004 and raised its 1st funding round 1 year after it was founded.

Where is Lentigen located?

Lentigen is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.

What does Lentigen do?

Lentigen was founded in 2004 in Gaithersburg, United States, focusing on the biotechnology sector. Lentiviral vectors are manufactured for translational research, including multi-lentiviral vector evaluation for construct assessment, custom concentrated vectors for feasibility studies, and chromatography-purified vectors for process evaluation. Operations support pre-clinical and clinical applications in gene therapy and related fields.

Who are the top competitors of Lentigen?

Lentigen's top competitors include Phase Genomics, Genedit and CellFE.

How many acquisitions has Lentigen made?

Lentigen has made 1 acquisition, including Living Pharma.

Who are Lentigen's investors?

Lentigen has 2 investors. Key investors include Miltenyi Biotec, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available